Frank Chip Brosius

机构：University of Arizona, University of Michigan · ORCID：0000-0002-4244-8335

发表论文 245 篇 · 总被引 15186 次 · h-index 64

代表论文

• Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials (2023 · BMJ · 被引 291)
• Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis (2022 · Diabetes Care · 被引 215)
• SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes (2023 · Journal of Clinical Investigation · 被引 115)
• Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes (2023 · Annals of Internal Medicine · 被引 102)
• APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans (2024 · New England Journal of Medicine · 被引 81)
• The chromatin landscape of healthy and injured cell types in the human kidney (2024 · Nature Communications · 被引 47)